03/29/2024
5:11 AM | Cyteir Therapeutics (Filer)
| Form 15-12G | |
03/25/2024
10:05 AM | Cyteir Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:16 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/21/2024
3:17 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/21/2024
3:17 PM | Cyteir Therapeutics (Filer)
| Form S-8 POS | |
03/20/2024
3:55 PM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:21 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
|
03/18/2024
6:23 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/18/2024
6:24 AM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/18/2024
5:07 AM | Cyteir Therapeutics (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
03/13/2024
11:15 PM | Cyteir Therapeutics (Filer)
| Form EFFECT | |
03/12/2024
3:30 PM | Cyteir Therapeutics (Filer)
| Form POS AM | |
03/12/2024
3:16 PM | Cyteir Therapeutics (Subject)
GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D/A | |
03/07/2024
3:31 PM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:10 PM | Cyteir Therapeutics (Issuer)
RENSCHLER MARKUS MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:11 PM | Cyteir Therapeutics (Issuer)
Gaiero David G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:36 PM | Cyteir Therapeutics (Subject)
Lightstone Ventures II, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
6:14 PM | Avidity Partners Management LP (Filed by)
Cyteir Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:28 PM | Cyteir Therapeutics (Subject)
GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D/A | |
02/08/2024
3:11 PM | Cyteir Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
12:40 PM | BML Investment Partners, L.P. (Filed by)
Cyteir Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024
8:30 AM | Cyteir Therapeutics (Subject)
HEDGEHOG CAPITAL LLC (Filed by)
| Form SC 13G/A | |
11/22/2023
12:47 PM | Cyteir Therapeutics (Issuer)
Gaiero David G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
12:48 PM | Cyteir Therapeutics (Issuer)
RENSCHLER MARKUS MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:00 PM | Cyteir Therapeutics (Subject)
HEDGEHOG CAPITAL LLC (Filed by)
| Form SC 13G | |
10/19/2023
3:07 PM | Cyteir Therapeutics (Subject)
GAMCO INVESTORS, INC. ET AL (Filed by)
| Form SC 13D | |
10/12/2023
3:14 PM | Cyteir Therapeutics (Filer)
| Form DEFM14A | |
10/12/2023
6:51 AM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
6:52 AM | Cyteir Therapeutics (Filer)
| Form DEFA14A | |
10/02/2023
3:44 PM | Cyteir Therapeutics (Filer)
| Form PREM14A | |
07/20/2023
7:01 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
7:27 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
3:56 PM | Cyteir Therapeutics (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
9:20 AM | Cyteir Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
07/03/2023
5:29 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
4:29 PM | Cyteir Therapeutics (Subject)
Secrist John Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
9:37 AM | Cyteir Therapeutics (Filer)
| Form DEFA14A | |
06/30/2023
9:22 AM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
8:35 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
5:02 PM | Cyteir Therapeutics (Subject)
Secrist John Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2023
6:17 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
1970’s computer coder Issues Shocking AI Warning (Ad) Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology…
Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans. Click here to watch his new video ASAP |
06/20/2023
4:53 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
7:18 PM | Cyteir Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
7:18 PM | Cyteir Therapeutics (Issuer)
Novo Holdings A/S (Reporting)
Novo Holdings A/S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
7:14 PM | Cyteir Therapeutics (Subject)
Novo Holdings A/S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
7:00 AM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
3:27 PM | Cyteir Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:07 PM | Cyteir Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
